Real-World Experience with Ceftolozane-Tazobactam for Multidrug-Resistant Gram-Negative Bacterial Infections

Our objective was to describe the prescribing practices, clinical characteristics, and outcomes of patients treated with ceftolozane-tazobactam (C/T) for multidrug-resistant (MDR) Gram-negative infections. This was a multicenter, retrospective, cohort study at eight U.S. medical centers (2015 to 201...

Full description

Saved in:
Bibliographic Details
Published in:Antimicrob Agents Chemother
Main Authors: Jorgensen, Sarah C. J., Trinh, Trang D., Zasowski, Evan J., Lagnf, Abdalhamid M., Simon, Samuel P., Bhatia, Sahil, Melvin, Sarah M., Steed, Molly E., Finch, Natalie A., Morrisette, Taylor, Estrada, Sandy J., Rosenberg, Joshua R., Davis, Susan L., Rybak, Michael J.
Format: Artigo
Language:Inglês
Published: American Society for Microbiology 2020
Subjects:
Clinical Therapeutics
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7179316/
https://ncbi.nlm.nih.gov/pubmed/31932379
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02291-19
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items